Panacea Journal of Medical Sciences 2021;11(2):326–330 Content available at: https://www.ipinnovative.com/open-access-journals Panacea Journal of Medical Sciences Journal homepage: http://www.pjms.in/ Original Research Article Antibiotic susceptibility of bacterial strains and bacteriological profile from patients with lower respiratory tract infections in a teaching hospital Ritu Vaish1,* 1Dept. of Microbiology, Prathima Institute of Medical Sciences, Nagunuru, Karimnagar, Telangana, India A R T I C L E I N F O Article history: Received 12-12-2020 Accepted 29-12-2020 Available online 25-08-2021 Keywords: LRTI Bacteriological profile Antibiotic susceptibility A B S T R A C T Background: Lower respiratory tract infections (LRTI) are one of the commonest health problems demanding frequent consultation and hospitalization. Unnecessary and inappropriate initial antibiotic therapy is a potentially modifiable factor that is associated with increased mortality in patients with serious infections. Aim of the study: To study bacterial profile and susceptibility pattern of lower respiratory tract infections in a teaching hospital. Materials and Methods: Prospective study done in the department of Microbiology at Prathima Institute of Medical Sciences, Nagunuru, Karimnagar, Telangana., Tover a period of 18 months ie from January 2019 to July 2020. A total of 120 samples from respiratory tract were studied for bacterial isolates and antibiotic susceptibility. Results: A total of 120 cases were studied. The male to female ratio was 2:1. Among the bacterial isolates, 76.6% were Gram negative bacilli and 23.3% were gram positive cocci. Among Gram negative bacteria, the predominant bacterial isolate was Klebisella. pneumoniae (45.8%) followed by Pseudomonas. aeruginosa (28.3%.) Conclusion: Present study, was based on the pattern of resistance to commonly used antibiotics by organisms causing lower respiratory tract infections (LRTIs) in our institute. This may help us to study the more susceptible group of drugs in our institute which would help prepare an antibiogram and develop a policy for rational antibiotic prescription. This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. For reprints contact: reprint@ipinnovative.com 1. Introduction Lower respiratory tract infections (LRTIs) are one of the serious communicable diseases and the 3rd leading cause of death globally, after ischaemic heart and cerebrovascular diseases. 1 In developing countries management of LRTIs is difficult in both children 2 and adults, 3 especially due to the issues associated with identification of the etiological agents and selection of appropriate antibiotics. LRTIs in adults include lower respiratory tract infections, acute bronchitis, influenza, * Corresponding author. E-mail address: rituvaish@gmail.com (R. Vaish). suspected or definite community-acquired pneumonia, acute exacerbation of chronic obstructive pulmonary disease (COPD) and bronchiectasis. 4 The etiological agents of LRTIs cannot be determined clinically and differ from area to area. 5 Gram-positive bacteria such as Staphylococcus aureus, Streptococcus pneumonia, etc. as well as Gramnegative bacteria such as Haemophilus influenzae, Pseudomonas, Acinetobacter, and Klebsiella species are recovered from LRTIs. 5,6 https://doi.org/10.18231/j.pjms.2021.066 2249-8176/© 2021 Innovative Publication, All rights reserved. 326 Vaish / Panacea Journal of Medical Sciences 2021;11(2):326–330 327 2. Aim of the study To study the bacteriological profile and susceptibility pattern of lower respiratory tract infections in a teaching hospital in karimnagar, Telangana 3. Materials and Methods The study was approved by the Institutional Ethics Committee. Written informed consent was obtained from all the cases included in the study. A written informed consent was obtained from all the participants included in the study. There were no ethical issues involved Prospective study done in in the department of Microbiology at Prathima Institute of Medical Sciences, Nagunuru, Karimnagar, Telangana. Over a period of 18 months from January 2019 to July 2020. There were a total of 220 cases of suspected LRTI of which 120 were studied. 3.1. Inclusion criteria 1. Patients who were willing to participate in the study. 2. Age from 5 year to 75 years. 3. Both genders 4. Patients clinically suspected for LRTIs. 5. Positive culture. 3.2. Exclusion criteria 1. Patients who were unwilling to participate in the study. 2. Patients suffering from tuberculosis. 3. Patients who had received antibiotics before sputum could be sent for culture and sensitivity. 3.3. Methodology The patients with lower respiratory tract infections visiting the department of Pulmonology were selected based upon the above criteria. A proper detailed clinical history was taken. All the relevant investigations were done including routine investigations such as hemogram, complete urine examination, and relevant biochemical investigations. Findings were recorded in a predesigned proforma. The procedure for collection of sputum samples was instructed to the patients in the department of microbiology. The sputum samples were collected into well labelled sterile, wide mouthed glass bottles with screw cap tops. Tracheal and bronchial alveolar fluid samples were sent from the department of pulmonology immediately without any delay, to the microbiology laboratory. Bacterial culture and antimicrobial susceptibility testing were done. The sputum samples were inoculated onto Blood agar plates, Chocolate agar plates and MacConkey agar plates. Blood agar plates and MacConkey agar plates were incubated aerobically at 37-degree Celsius for 24 hours. The inoculums on the plate were streaked with a sterile wire loop and observed for growth of colonies while Chocolate agar plates were incubated in an atmosphere containing extra carbon dioxide in candle jar. All the bacteria were isolated and identified using morphology, microscopy. 3.4. Antimicrobial susceptibility testing Antimicrobial susceptibility testing was performed by modified Kirby Bauer method as per the Clinical Laboratory Standards Institute (CLSI) guidelines. 7,8 For gram negative organisms, antibiotics tested were ampicillin (AMP), piperacillin (PC), amoxycillin-clavulanic acid (AMC), ampicillin-sulbactam (AS), ceftriaxone (CTR), cefotaxime (CTX), ceftazidime (CAZ), cefoxitin (CN), cefepime (CPM), piperacillin- tazobactam (PT), gentamicin (GM), amikacin (AK), imipenem (IMP), meropenem (MRP), ciprofloxacin(CIP) and trimethoprim- sulphamethoxazole (COT). For Gram positive organisms, antibiotics tested were penicillin (P), amoxycillin-clavulanic acid (AMC), ceftriaxone (CTR), cefoxitin (CN), erythromycin (ER), clindamycin (CD), vancomycin (VA), linezolid (LZ), gentamicin (GM), amikacin (AK), ciprofloxacin (CIP). The antibiogram of each confirmed isolate was studied and the susceptibility results were compiled. 4. Observations and Results A total of 220 samples were collected and screened, of which 120 were pathogenic. Data was made for these120 cases. Table 1: Age distribution Age distribution in years No. of cases Percent (%) 5-15 02 1.6% 16-25 03 2.5% 26-35 08 6.6% 36-45 24 20% 46-55 41 34.1% 56-65 27 22.5% 66-75 15 12.5% Total 120 100% In the present study age distribution ranged from 5 years to 75 years. Most common age group affected was between 46-55 years, followed by 22.5% among 56 – 65 years. In the present study males 66.6% (80/120) were predominant when compared to females 33.3% (40/120) and the male to female ratio was 2:1. 328 Vaish / Panacea Journal of Medical Sciences 2021;11(2):326–330 4.1. Distribution of clinical features The common clinical features were fever in 25 (20.8%) cases, cough in 30 (25%) cases, fever and cough in 40 (33.3%) cases, breathlessness in 10 (8.3%) cases, chest pain in 5 (4.1%) cases, and myalgia in 10 (8.3%) cases. Pneumonia 54.1% (65/120) cases was the most common clinical diagnosis in our study followed by bronchiectasis in 29.1% (35/120) cases and 16.6% (20/120) constituted bronchial asthma. Fig. 1: Types of samples In the present study, Sputum swabs constituted 45% (54/120), Pleural fluid 8.3% (10/120), Tracheal aspirate 25%(30/120), Bronchoalveolar fluid 16.6% (20/120) and Endotracheal tube secretions constituted 5%(06/120) samples. Table 2: Distribution of bacterial isolates Bacterial isolates No. of cases Percent (%) Klebsiella pneumoniae 55 45.8% Pseudomonas aeruginosa 34 28.3% E.coli 03 2.5% Staphaloccocus aureus 10 8.3% Streptococcus pneumoniae 18 15% Total 120 100% In the present study, among the bacterial isolates76.6% (92/120) were Gram negative bacilli and 23.3% (28/120) were Gram positive cocci. Among gram negative bacteria, the predominant bacteria isolated was K.pneumoniae 45.8% followed by P.aeruginosa 28.3% and 2.5% E.coli. Among Gram positive bacteria, Streptococcus pneumoniae 12.5% were predominant cooci isolated and S.aureus constituted 8.3%, followed by Enterococci 5%. In the present study, K. pneumoniaewas the most common prevalent bacteria with a susceptibility of 90% to Ceftazidime+Clavulanate, 82% to Ceftriaxone, Ciprofloxacin 56%, Gentamicin 76%, Imipenem 80%, Piperacillin+Tazobactum 90%, Vancomycin 68%, Erythromycin 72%, Linezolid 66%, COT 70%, Tetracyclines 66%. P.aeruginosa showed a susceptibility of 92% to Ceftazidime+Clavulanate, 88% to Ceftriaxone, Ciprofloxacin 60%, Gentamicin 80%, Imipenem 92%, Piperacillin+Tazobactum 92%,Ampicillin; 78%, Linezolid 68%, COT 70%, Tetracyclines 72%. Amongst the gram-positive cocci, Streptococcus pneumoniae showed susceptibility of 90% to Ceftriaxone, Ciprofloxacin 72%, Gentamicin 70%, Imipenem 88%, Piperacillin+Tazobactum 78%, Vancomycin 78%, Erythromycin 80%, ampiciilin 78% Linezolid 70%, COT 76%, Tetracyclines 60%. V Staphylococcus aureus strains had susceptibility of 92% to Ceftazidime+Clavulanate, 86% to Ceftriaxone, Ciprofloxacin 70%, Cefoxitin 82%, Gentamicin 76%, Imipenem 80%, Piperacillin+Tazobactum 90%, Vancomycin 80%, Erythromycin 82%, Ampicillin 80%, Linezolid 82%, COT 78%, Tetracyclines 80%. 5. Discussion 5.1. Comparative studies related to age distribution In the present study, age distribution varied from 5 to 75 years. Most common age group was between 46-55 years with a mean age of 48 years, followed by 22.5% among 56- 65 years. This was compared with other studies. In the study by Tchatchouang S et al 9 the patient age ranged from 18 to 94 years with a median age of 50 years. In the study by Nurahmed N et al 10 the mean age of was 38±14 years, and the highest proportion of participants was in the age range of 18–27 years (31.1%), followed by the age range 28–37 years (22.1%). 5.2. Comparative studies related to gender distribution In the present study, males were predominant when compared to females and the male: female ratio was 2:1. Similar findings were observed by Tchatchouang S et al 9 where they also observed the male predominance and male/female sex ratio of 1.8. Nurahmed N et al 10 noted slight female predominance in their study with 112 males and 128 females. 5.3. Comparative studies related to clinical features In our study, the most predominant clinical symptom was cough with fever that constituted about 33.3%, next common was only cough 25%, then fever 20.8%, chest pain in 4.1%, breathlessness in 8.3% and myalgia in 8.3% cases. Tchatchouang S et al 9 in their study observed the most predominant symptoms as cough (87.2%), dyspnoea (85.8%), breathlessness (83%), asthenia (75.9%), fever (63.8%), chest pain (60.3%), and myalgia (42.6%). 5.4. Comparative studies related to site of swabs In the present study, among 120 samples collected, sputum swabs constituted 45%, pleural fluid 8.3%, tracheal aspirates 25%, bronchoalveolar fluid 16.6%, and endotracheal tube secretions were 5%. In a study done Vaish / Panacea Journal of Medical Sciences 2021;11(2):326–330 329 Table 3: Distribution of antibiotic susceptibility of bacterial isolates Antibiotics Klebsiella pneumonia Psuedomonas aeruginosa Streptococcus pneumonia Staphylococcus aureus Ceftazidime+Clavulanate 90% 92% NA 92% Ceftriaxone 82% 88% 90% 86% Ciprofloxacin 56% 60% 72% 70% Cefoxitin NA NA NA 82% Gentamicin 76% 80% 70% 76% Imipenem 80% 92% 88% 80% Piperacillin+Tazobactum 90% 92% 78% 90% Vancomycin 68% NA 78% 80% Erythromycin 72% NA 80% 82% Ampicillin; NA 78% 78% 80% Linezolid 66% 68% 70% 82% COT 70% 70% 76% 78% Tetracyclines 66% 72% 60% 80% by SarmahN et al 11 among the 1376 samples included, there were tracheal aspirate (87), sputum (1101), throat swabs (168) and bronchoalveolar lavage (20). Whereas Manikandan et al 12 included 225 (90.7%) sputum samples and 112 (33.2%) throat swab samples. 5.5. Comparative studies related tobacterial isolates In the present study, among the bacterial isolates 74.1% (89/120) were Gram negative bacilli isolatedand 25.8% (31/120) were Gram positive cocci. Among Gram negative bacteria (GNB), the predominant bacterial isolated was K.pneumoniae 45.8% followed by P.aeruginosa 28.3%. Among gram positive bacteria Streptococcus pneumoniae 12.5% were predominant cooci isolated and S.aureus constituted 8.3%,followed by Enterococci 5%. In the study by Regha IR et al 13 among the bacterial isolates 244 (84.7%) were GNB and remaining 44 (15.3%) were Gram positive cocci. The predominant pathogen isolated was K.pneumoniae (31.1%) followed by P.aeruginosa (30.2%). Among gram positive bacteria, S.aureus (4.5%) and Strp.pyogenes (4.5%) were predominant organisms followed by Enterococci (4.2%). In Manikandan et al study 12 the most common organism isolated was Streptococcus pneumoniae (36%), Klebsiella pneumoniae (28.4%), Staphylococcus aureus (24%), Pseudomonas aeruginosa (11%) and Escherichia coli (0.6%).The Gram positive cocci constituted 202 (60%) while Gram negative bacilli constituted 135 (40%) of the total isolates. Nurahmed N et al 10 reported the prevalence of K. pneumoniae was the highest [32 (39.5%)], followed by S. pneumoniae [15(18.5%)], Ecoli [13(16%)], and Citrobacter [7(8.6%)]. 5.6. Comparative studies related to antimicrobial sensitivity In the present study, K. pneumonia was the most common prevalent bacteria with a susceptibility of 90% to Ceftazidime+Clavulanate. Streptococcus pneumoniae showed susceptibility of 90% to Ceftriaxone, Staphylococcus aureus strains showed susceptibility of 92% to Ceftazidime+Clavulanate andvancomycin 80%. Regha IR et al 13 observed Gram positive organisms with highest sensitivity towards Vancomycin followed by Linezolid. All (100%) of Strp.pyogenes and Strp.pneumoniae were sensitive to Penicillin. Sarmah N et al 11 observed that K. pneumoniae exhibited a higher sensitivity towards Polymixin B and Tigecycline. Gram positive organisms on the other hand showed 100% susceptibility to Vancomycin and Linezolid followed by high susceptibility to Teicoplanin. Nurahmed N et al 10 noted most effective antibiotic for K. pneumoniae to be meropenem, with 100% sensitivity (32/32). Manikandan et al 12 observedS. pneumoniae was the most prevalent bacteria with a susceptibility of 98% to Amikacin. The susceptibility profile of S. aureus was 97% to Amikacin.K. pneumoniae was the second most prevalent bacteria with a susceptibility of 95% to Amikacin. P. aeruginosa had a susceptibility profile of 87% to Amikacin. 6. Conclusion Present study, was based on the pattern of resistance to commonly used antibiotics by organisms causing lower respiratory tract infections (LRTIs) in our Institute. This may help us to study the more susceptible group of drugs in our institute which would help to prepare an appropriate antibiogram for rational antibiotic prescription. 7. Limitations The present study has a number of limitations, and to appreciate the findings, some issues need to be addressed as Small sample size of the study. A distinction between community-acquired and hospital-acquired infections could not be made. Resultant morbidity and mortality was not 330 Vaish / Panacea Journal of Medical Sciences 2021;11(2):326–330 analysed in study. 8. Conflict of Interest The authors declare that there are no conflicts of interest in this paper. 9. Source of Funding None. References 1. World Health Organization (WHO). The top 10 causes of death. Geneva: WHO; 2017. Available from: http://www.who.int/ mediacentre/factsheets/fs310/en/. 2. Niederman MS, Krilov LR. Acute lower respiratory infections in developing countries. Lancet. 2013;381(9875):1341–42. 3. Khan S, Priti S, Ankit S. Bacteria etiological agents causing lower respiratory tract infections and their resistance patterns. Iran Biomed J. 2015;19(4):240–6. 4. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J. 2005;26:1138–80. doi:10.1183/09031936.05.0005570. 5. Ozyilmaz E, Akan OA, Gulhan M, Ahmad K, Nagatake T. Major bacteria of community-acquired respiratory tract infections in Turkey. Jpn J Infect Dis. 2005;58(1):50–2. 6. Erling V, Jalil F, Hanson LA, and SZ. The impact of climate on the prevalence of respiratory tract infection in early childhood in Lahore. Pakistan J Pub Health. 1999;21(3):331–9. doi:10.1093/pubmed/21.3.331. 7. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single diskmethod. Am J Clin Pathol. 1966;45(4):493–6. 8. Clinical and Laboratory Standard Institute 2012: Performance standard for antimicrobial susceptibility testing: twenty second informational supplement. CLSI document M100. 2012;32(3):22. 9. Tchatchouang S, Nzouankeua, Kenmoe S, Ngando L, Penlap V, Fonkoua MC, et al. Bacterial Aetiologies of Lower Respiratory Tract Infections among Adults in Yaoundé, Cameroon. BioMed Res Int. 2019;doi:10.1155/2019/4834396. 10. Nurahmeda N, Kedira S, Fantahunb S, Getahunc M, Mohammedd A, Mohammeda A, et al. Bacterial profile and antimicrobial susceptibility patterns of lower respiratory tract infection among patients attending selected health centers of Addis Ababa, Ethiopia . Egypt J Chest Dis Tuberc. 2020;doi:10.4103/ejcdt.ejcdt_68_19. 11. Sarmah N, Sarmah A, Das DK. A Study on the Microbiological Profile of Respiratory Tract Infection (RTI) in Patients Attending GauhatiMedical College & Hospital. AIMDR Ann Int Med Dental. 2016;Available from: https://pesquisa.bvsalud.org/portal/resource/pt/ sea-177811. 12. Manikandan C, Amsath A. Antibiotic susceptibility of bacterial strains isolated from patients with respiratory tract infections. Int J Pure Appl Zool. 2013;1(1):61–9. 13. Regha IR, Sulekha B. Bacteriological profile and antibiotic susceptibility patterns of lower respiratory tract infections in a tertiary care hospital, Central Kerala. Int J Med Microbiol Tropical Dis. 2018;4(4):186–90. Author biography Ritu Vaish, Associate Professor Cite this article: Vaish R. Antibiotic susceptibility of bacterial strains and bacteriological profile from patients with lower respiratory tract infections in a teaching hospital. Panacea J Med Sci 2021;11(2):326-330. http://www.who.int/mediacentre/factsheets/fs310/en/ http://www.who.int/mediacentre/factsheets/fs310/en/ http://dx.doi.org/10.1183/09031936.05.0005570 http://dx.doi.org/10.1093/pubmed/21.3.331 http://dx.doi.org/10.1155/2019/4834396 http://dx.doi.org/10.4103/ejcdt.ejcdt_68_19 https://pesquisa.bvsalud.org/portal/resource/pt/sea-177811 https://pesquisa.bvsalud.org/portal/resource/pt/sea-177811